Patients' Experiences of Care With or Without the Support of an Interactive App During Neoadjuvant Chemotherapy for Breast Cancer: Interview Study
- PMID: 35969443
- PMCID: PMC9412756
- DOI: 10.2196/39983
Patients' Experiences of Care With or Without the Support of an Interactive App During Neoadjuvant Chemotherapy for Breast Cancer: Interview Study
Abstract
Background: Neoadjuvant chemotherapy (NACT) is often recommended for patients with breast cancer with more aggressive tumor characteristics. As with all chemotherapies, they can cause substantially disturbing symptoms. Most patients receive their treatment as outpatients, which means that they must take responsibility for self-care and management of symptoms at home for a long period. Patients with breast cancer undergoing chemotherapy may not receive sufficient support for management of treatment-related symptoms. For patients undergoing NACT, it has been concluded that information and supportive needs are not always met. In our previous study, the use of mobile health to support patients with breast cancer undergoing NACT reduced symptoms during treatment with the support of an interactive app. Therefore, it is important to investigate how patients experience their care and explore any specific contribution that the app may have brought in care.
Objective: This study aims to explore patients' experiences of care with or without the support of an interactive app during NACT for breast cancer.
Methods: This qualitative study was part of a larger randomized controlled trial and included 40 individual face-to-face interviews conducted with patients in both intervention and control groups after the end of NACT. The interviews were audio recorded, and the data were analyzed inductively using thematic analysis.
Results: No major differences in experience of care were observed between the groups. A total of 4 overarching themes emerged. In the first theme, The health care context, patients described care as assessible, although sometimes there was a lack of time and continuity with nurses. In the second theme, Being a recipient of care, it emerged that the patients experienced a warm and positive atmosphere at the clinics. In the third theme, Taking an active role as a patient, patients described being active in searching for information and various ways of participation in their own care. In the fourth theme, The value of the app, patients who had used the app experienced it as a complementary source of information, creating a sense of security. Using the app provided patients with the support of being contacted by a nurse if needed, enabled self-care, and facilitated the planning of daily activities.
Conclusions: Overall, patients' experiences of care were similar and mostly positive. However, for patients using the app, it provided additional support for information and self-care and enhanced participation in their own care. The easy access to a nurse gave patients a sense of security. The findings suggest integrating an interactive app as a complement to standard care to support patients with breast cancer during treatment.
International registered report identifier (irrid): RR2-DOI: 10.1186/s12885-017-3450-y.
Keywords: breast cancer; experiences of care; mHealth; mobile app; mobile health; mobile phone; neoadjuvant chemotherapy; patient participation.
©Maria Fjell, Ann Langius-Eklöf, Marie Nilsson, Kay Sundberg. Originally published in JMIR Nursing (https://nursing.jmir.org), 11.08.2022.
Conflict of interest statement
Conflicts of Interest: None declared.
Figures
Similar articles
-
Using an Interactive App for Symptom Reporting and Management Following Pancreatic Cancer Surgery to Facilitate Person-Centered Care: Descriptive Study.JMIR Mhealth Uhealth. 2020 Jun 17;8(6):e17855. doi: 10.2196/17855. JMIR Mhealth Uhealth. 2020. PMID: 32554375 Free PMC article.
-
Engagement in an Interactive App for Symptom Self-Management during Treatment in Patients With Breast or Prostate Cancer: Mixed Methods Study.J Med Internet Res. 2020 Aug 10;22(8):e17058. doi: 10.2196/17058. J Med Internet Res. 2020. PMID: 32663140 Free PMC article. Clinical Trial.
-
Adherence to Report and Patient Perception of an Interactive App for Managing Symptoms During Radiotherapy for Prostate Cancer: Descriptive Study of Logged and Interview Data.JMIR Cancer. 2017 Oct 31;3(2):e18. doi: 10.2196/cancer.7599. JMIR Cancer. 2017. PMID: 29089290 Free PMC article.
-
Testing an app for reporting health concerns-Experiences from older people and home care nurses.Int J Older People Nurs. 2018 Jun;13(2):e12181. doi: 10.1111/opn.12181. Epub 2017 Dec 5. Int J Older People Nurs. 2018. PMID: 29210218
-
Mobile care app development process: using the ADDIE model to manage symptoms after breast cancer surgery (step 1).Discov Oncol. 2023 May 9;14(1):63. doi: 10.1007/s12672-023-00676-5. Discov Oncol. 2023. PMID: 37160467 Free PMC article. Review.
Cited by
-
Addressing the unmet needs of women with breast cancer in Mexico: a non-randomised pilot study of the digital ePRO intervention.BMJ Open. 2024 Jun 21;14(6):e087240. doi: 10.1136/bmjopen-2024-087240. BMJ Open. 2024. PMID: 38908841 Free PMC article.
-
Psychological distress and coping strategies in breast cancer patients under neoadjuvant therapy: A systematic review.Womens Health (Lond). 2024 Jan-Dec;20:17455057241276232. doi: 10.1177/17455057241276232. Womens Health (Lond). 2024. PMID: 39287572 Free PMC article.
References
-
- Cain H, Macpherson IR, Beresford M, Pinder SE, Pong J, Dixon JM. Neoadjuvant therapy in early breast cancer: treatment considerations and common debates in practice. Clin Oncol (R Coll Radiol) 2017 Oct;29(10):642–52. doi: 10.1016/j.clon.2017.06.003. https://linkinghub.elsevier.com/retrieve/pii/S0936-6555(17)30278-9 S0936-6555(17)30278-9 - DOI - PubMed
-
- Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn H, Thürlimann B, St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017. André F, Baselga J, Bergh J, Bonnefoi H, Brucker SY, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang C, Huober J, Hussein K, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJ, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen international expert consensus conference on the primary therapy of early breast cancer 2017. Ann Oncol. 2017 Aug 01;28(8):1700–12. doi: 10.1093/annonc/mdx308. https://linkinghub.elsevier.com/retrieve/pii/S0923-7534(19)32181-7 S0923-7534(19)32181-7 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous